Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05190757 · ClinicalTrials.gov registry record
Supraglottic Airway Needed To Achieve Ventilation
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 54
- Enrollment target
NCT05190757: Completed study, sponsored by Mayo Clinic.
NCT05190757 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05190757 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this research is to compare if insertion of laryngeal mask airway (LMA) vs. use of face mask, will reduce the time needed to achieve adequate ventilation prior to insertion of the breathing tube.
Primary Outcome
Compare time needed to achieve ventilation
Interventions
- OTHER Airway and Ventilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-01-21 |
| Est. Completion | 2023-02-16 |
What the finished NCT05190757 record still lists
NCT05190757 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Airway and Ventilation is the first listed.
NCT05190757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05190757 about?
NCT05190757 is a clinical study titled "Supraglottic Airway Needed To Achieve Ventilation". The purpose of this research is to compare if insertion of laryngeal mask airway (LMA) vs. use of face mask, will reduce the time needed to achieve adequate ventilation prior to insertion of the breathing tube.
What is the current status of trial NCT05190757?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2022-01-21. Estimated completion is 2023-02-16.
What interventions are being tested in trial NCT05190757?
The interventions under investigation include: Airway and Ventilation (OTHER).
Who is sponsoring clinical trial NCT05190757?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI